VMD2-ophNdi1 was expressed from recombinant AAV2/8 (AAV2/8-VMD2-ophNdi1; Figure 1) and its therapeutic potential was investigated in the Cfh−/− genetic and NaIO3-induced murine models of AMD. Here, BEST1 is linked to age-related macular degeneration.